细乳液聚合法制备有机/无机纳米复合材料

无机纳米粒子的引入可以使聚合物材料获得抗菌、导电和防紫外等诸多特性,但无机纳米粒子在聚合物基质中易团聚、引入量少,难以充分发挥其优点。细乳液聚合法基于其独特的成核方式--液滴成核,能够提高无机纳米粒子在聚合物基中的分散性和引入量,且复合材料的形貌易于控制,是目前制备特殊形貌有机/无机纳米复合材料的一种有效手段。本文介绍了有机/无机复合纳米材料的细乳液制备过程,综述了近年来不同无机纳米粒子与有机基质复合的研究进展,例如：纳米SiO₂、纳米ZnO、金属纳米粒子、纳米氧化石墨烯等。最后就其发展现状提出了几点建议。     

表面引发原子转移自由基聚合法合成无机/有机核壳复合纳米粒子

原子转移自由基聚合(ATRP)是目前为止最具工业化应用前景的活性/可控自由基聚合方法之一,其最大特点是可以得到分子量分布窄、链结构规整的聚合物,而且可聚合的单体种类多,反应条件温和并易控制。表面引发ATRP(SI-ATRP)特别适合于无机材料表面接枝聚合物或无机/有机复合材料的制备,近年来引起了国内外研究者的高度关注。本文首先对SI-ATRP的反应过程与特点做了阐述,然后重点述评了用SI-ATRP法合成以非金属氧化物纳米粒子、金属氧化物纳米粒子、金属纳米粒子或其他无机纳米粒子为核的无机/有机复合纳米粒子的研究进展,最后对未来用SI-ATRP法合成无机/有机复合纳米粒子的发展方向和研究前景进行展望。     

无机纳米粒子表面引发接枝聚合

无机纳米粒子表面引发聚合反应是无机纳米粒子—有机聚合物杂化复合材料制备的一种重要途径。分子自组装技术的发展使得各种类型的聚合反应都有转移至无机纳米粒子表面进行的可能。本文综述了表面引发聚合反应用于制备高键合密度的聚合物接技无机纳米粒子的研究进展。     

反相微乳液模板原位聚合制备纳米氯化银/聚甲基丙烯酸甲酯及其结构表征

用甲基丙烯酸甲酯(MMA)作油相,反相胶束微乳液作为模板,制备了纳米氯化银(AgCl)粒子,再进行原位聚合制备了纳米氯化银/聚甲基丙烯酸甲酯(AgCl/PMMA)复合材料.透射电镜(TEM)分析表明,纳米AgCl的尺寸为20～80 nm.扫描电镜(SEM)测试表明纳米AgCl粒子均匀地存在于PMMA基材中.红外分析证明,胶束中水和表面活性剂AOT的羰基在MMA聚合后微观环境发生变化,纳米粒子同聚合物之间有吸附行为.动态力学(DMTA)分析复合材料,发现纳米AgCl粒子与聚合物之间存在强烈相互作用,形成了中间相层(interphase layer),改变了聚合物的动态力学性能.     

聚丙烯/PMMA/CaCO3纳米复合材料的制备、结构与力学性能

分别将经不同表面处理的纳米碳酸钙粒子与聚合物PP共混,制备PP／CaCO3和PP／PMMA／CaCO3纳米复合材料。用TEM观察了表面处理后纳米粒子的粒径与分散情况,发现复合粒子分散较均匀。用DSC与WAXD研究了复合材料的结晶行为,发现原位聚合制备的PMMA／CaCO3纳米复合粒子与PP共混后,PP有异相成核作用,出现了不稳定的PPβ晶型。PP／PMMA／CaCO3纳米复合材料力学性能有大幅度的提高。     

智能聚合物包覆的金纳米粒子*

本文综述了智能聚合物包覆的金纳米粒子的研究进展,重点介绍了智能聚合物包覆金纳米粒子的制备方法,包括原位合成法、配体置换法、表面引发聚合法和表面接枝聚合法等,以及智能聚合物包覆的金纳米粒子的智能响应类型,如温度敏感型、pH敏感型、pH/电解质双重敏感型、pH/温度双重敏感型、溶剂敏感型等。     

聚合物基无机纳米复合材料的制备方法Ⅱ.直接分散法和同时形成法

聚合物基无机纳米复合材料制备的关键问题是无机纳米粒子在聚合物基体中保持其纳米尺度的分散,本文主要讨论直接分散法、同时形成法制备聚合物基无机纳米材料的基本原理和技术要点。     

聚(苯乙烯-马来酸酐)/Fe3O4纳米杂化材料的制备与表征

采用2,2,6,6-四甲基-1-哌啶氧化物(TEMPO)的溴盐对化学共沉淀法制备的Fe3O4纳米粒子进行表面修饰,以该粒子为过氧引发剂,苯乙烯(St)、马来酸酐(MA)为单体,采用"活性"/可控自由基聚合技术在粒子表面原位引发聚合,制备了聚(苯乙烯-马来酸酐)/Fe3O4纳米杂化材料,并对纳米Fe3O4及杂化材料进行了FT-IR、XRD、TGA、TEM和GPC表征。结果表明,所制备的纳米杂化材料的平均粒径约为70 nm,磁性粒子表面的聚合物分子链随着聚合时间的增长而增长。振动样品磁强计测试结果显示,在室温、外加磁场下,该纳米杂化材料呈现超顺磁性,饱和磁化强度随着包覆聚合物量的增加而降低。     

乳液法制备聚合物纳米粒子及其结构表征与应用

本文详细地介绍了乳液法聚合物纳米粒子的各种制备方法及其结构表征,阐述了聚合物纳米粒子结构和性能上的特殊性,并展望了其应用前景和发展方向。     

两端系留纳米粒子聚合物的分子动力学模拟

两端系留纳米粒子聚合物是研究末端对聚合物链弛豫行为影响的优选分子模型.本文构建了两端系留纳米粒子聚合物模型,运用粗粒化分子动力学方法研究了两端系留纳米粒子聚合物的特征温度和弛豫行为,探讨了纳米粒子半径和聚合物链长对玻璃化转变温度、结晶温度和介电性能的影响.研究表明,聚合物两端纳米粒子的存在可延缓聚合物链的弛豫并促进结晶,使两端系留纳米粒子聚合物的玻璃化转变温度和结晶温度均增加.研究结果与相关的实验报道吻合,可加深对两端系留纳米粒子聚合物结构和性能的理解.     

Multiplex fluorescence imaging-guided programmed delivery of doxorubicin and curcumin from a nanoparticles/hydrogel system for synergistic chemotherapy

Synergistic chemotherapy of doxorubicin and curcumin (CUR) is an important strategy for cancer therapy to compensate for the single drug chemotherapy. Programmed and precise delivery of drugs plays a crucial role for optimizing the mode of administration and revealing the mechanism of synergistic chemotherapy. Herein, multiplex fluorescence imaging-guided programmed delivery of doxorubicin and CUR was achieved by a nanoparticles/hydrogel system for synergistic chemotherapy. CUR-loaded nanoparticles and doxorubicin were co-loaded into hydrogel to construct a synergistic chemotherapy drug delivery system. The hydrogel-nanoparticles combined system can effectively achieve the programmed delivery of hydrophilic drug and hydrophobic drug for the synergistic chemotherapy. They exerted the on-demand spatiotemporal delivery of doxorubicin and CUR. The combined chemotherapy system significantly inhibited the tumor growth compared to single therapy. Moreover, the programmed delivery of doxorubicin and CUR was visualized precisely based on their self-fluorescence instead of extra fluorescent tags at the cellular level and in vivo lever using multiplex fluorescence imaging technology. It afforded an imaging guidance for the controllable synergistic chemotherapy based on programmed delivery.     

Preparation and Characterization of Thermosensitive Nanoparticles for Targeted Drug Delivery

In this study, we have reported novel thermosensitive nanoparticles formulated by an emulsion-solvent evaporation technique using acetaminophen (AAP) as a model drug. The high entrapment efficiency of nanoparticles was 68.56%, particle size about 240.6 nm and zeta potential ?27 mV. Furthermore, the drug release was also investigated both at 37°C and 42°C, respectively. The goal of our study was to obtain a targeted drug delivery system, exploiting the temperature-sensitive behavior. In contrary to normal temperature (37°C), the release rate of AAP was found to noticeably increase at high temperature (42°C) with a larger cumulative amount of drug released. In this way, it would lead to production of nanoparticles having a high thermosensitive behavior on drug release. Thus, this new strategy has the potential to control drug release at the diseased site for targeted drug delivery system (TDDS) with positive temperature-controlled.     

Fluorescent Protein Capped Mesoporous Nanoparticles for Intracellular Drug Delivery and Imaging

A multifunctional system for intracellular drug delivery and simultaneous fluorescent imaging was constructed by using histidine‐tagged, cyan fluorescent protein (CFP)‐capped magnetic mesoporous silica nanoparticles (MMSNs). This protein‐capped multifunctional nanostructure is highly biocompatible and does not affect cell viability or proliferation. The CFP acts not only as a capping agent, but also as a fluorescent imaging agent. The nanoassembly was activated by histidine‐based replacement, leading to release of drug molecules encapsulated in the nanopores into the bulk solution. The fluorescent imaging functionality would allow noninvasive tracking of the nanoparticles in the body. By combining the drug delivery with cell‐imaging capability, these nanoparticles may provide valuable multifunctional nanoplatforms for biomedical applications.     

Preparation and Characterization of a Novel Drug Delivery System: Biodegradable Nanoparticles in Thermosensitive Chitosan/Gelatin Blend Hydrogels

A novel injectable in situ gelling drug delivery system (DDS) consisting of biodegradable N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride (HTCC) nanoparticles and thermosensitive chitosan/gelatin blend hydrogels was developed for prolonged and sustained controlled drug release. Four different HTCC nanoparticles, prepared based on ionic process of HTCC and oppositely charged molecules such as sodium tripolyphosphate, sodium alginate and carboxymethyl chitosan, were incorporated physically into thermosensitive chitosan/gelatin blend solutions to form the novel DDSs. Resulting DDSs interior morphology was evaluated by scanning electron microscopy. The effect of nanoparticles composition on both the gel process and the gel strength was investigated from which possible hydrogel formation mechanisms were inferred. Finally, bovine serum albumin (BSA), used as a model protein drug, was loaded into four different HTCC nanoparticles to examine and compare the effects of controlled release of these novel DDSs. The results showed that BSA could be sustained and released from these novel DDSs and the release rate was affected by the properties of nanoparticle: the slower BSA release rate was observed from DDS containing nanoparticles with a positive charge than with a negative charge. The described injectable drug delivery systems might have great potential application for local and sustained delivery of protein drugs.     

Synthesis of a new nanoparticle system based on electrostatic alginate‐piperazine interactions

Advanced drug delivery system development is very important for the cancer therapies. The fixing of specific targeting ligands onto biodegradable carriers can add specificity to the usual chemotherapeutical treatments that current chemotherapies lack of. This study describes the preparation of a new nanoparticle system based on electrostatic interactions between alginate and piperazine. Nanoparticles with a negative surface charge were prepared through the electrostatic interaction between alginate and piperazine under acid aqueous condition. This kind of interactions and materials has never been used before to produce nanoparticles. This nanoparticle system has been designed to be used as a carrier where superficial carboxylate groups are the binding site for different kind of molecules, for example, proteins and organic molecules. Afterwards, surface engineering was performed on the nanoparticles produced; cisplatin and epidermal growth factor (EGF) were covalently linked on the surface of the nanoparticle using reagents by carbodiimide chemistry to give a covalent bond between EGF and nanoparticles and between cisplatin and nanoparticles. As a result, this study reports the development of a potential advanced drug delivery system, which in the future will enable clinical trials in animals and humans. Copyright © 2015 John Wiley & Sons, Ltd.     

Prussian Blue Derived Nanoporous Iron Oxides as Anticancer Drug Carriers for Magnetic‐Guided Chemotherapy

New nanoporous iron oxide nanoparticles with superparamagnetic behavior were successfully synthesized from Prussian blue (PB) nanocubes through a thermal conversion method and applied to the intracellular drug‐delivery systems (DDS) of bladder cancer cells (i.e., T24) with controlled release and magnetic guiding properties. The results of the MTT assay and confocal laser scanning microscopy indicate that the synthesized iron oxide nanoparticles were successfully uptaken by T24 cells with excellent biocompatibility. An anticancer drug, that is, cisplatin, was used as a model drug, and its loading/release behavior was investigated. The intracellular drug delivery efficiency was greatly enhanced for the cisplatin‐loaded, PB‐derived, magnetic‐guided drug‐delivery system compared with the non‐drug case. The synthesized nanomaterials show great potential as drug vehicles with high biocompatibility, controlled release, and magnetic targeting features for future intracellular DDS.     

A New Porphyrin for the Preparation of Functionalized Water-Soluble Gold Nanoparticles with Low Intrinsic Toxicity

A potential new photosensitizer based on a dissymmetric porphyrin derivative bearing a thiol group was synthesized. 5-[4-(11-Mercaptoundecyloxy)-phenyl-10,15,20-triphenylporphyrin (PR-SH) was used to functionalize gold nanoparticles in order to obtain a potential drug delivery system. Water-soluble multifunctional gold nanoparticles GNP-PR/PEG were prepared using the Brust–Schiffrin methodology, by immobilization of both a thiolated polyethylene glycol (PEG) and the porphyrin thiol compound (PR-SH). The nanoparticles were fully characterized by transmission electron microscopy and ¹H nuclear magnetic resonance spectroscopy, UV/Vis absorption spectroscopy, and X-ray photoelectron spectroscopy. Furthermore, the ability of GNP-PR/PEGs to induce singlet oxygen production was analyzed to demonstrate the activity of the photosensitizer. Cytotoxicity experiments showed the nanoparticles are nontoxic. Finally, cellular uptake experiments demonstrated that the functionalized gold nanoparticles are internalized. Therefore, this colloid can be considered to be a novel nanosystem that could potentially be suitable as an intracellular drug delivery system of photosensitizers for photodynamic therapy.     

Recent advances in liposomal nanohybrid cerasomes as promising drug nanocarriers

Liposomes have been extensively investigated as possible carriers for diagnostic or therapeutic agents due to their unique properties. However, liposomes still have not attained their full potential as drug and gene delivery vehicles because of their insufficient morphological stability. Recently, a super-stable and freestanding hybrid liposomal cerasome (partially ceramic- or silica-coated liposome) has drawn much attention as a novel drug delivery system because its atomic layer of polyorganosiloxane surface imparts higher morphological stability than conventional liposomes and its liposomal bilayer structure reduces the overall rigidity and density greatly compared to silica nanoparticles. Cerasomes are more biocompatible than silica nanoparticles due to the incorporation of the liposomal architecture into cerasomes. Cerasomes combine the advantages of both liposomes and silica nanoparticles but overcome their disadvantages so cerasomes are ideal drug delivery systems. The present review will first highlights some of the key advances of the past decade in the technology of cerasome production and then review current biomedical applications of cerasomes, with a view to stimulating further research in this area of study.     

Tannic acid-coated zeolite Y nanoparticles as novel drug nanocarrier with controlled release behavior and anti-protozoan activity against Trichomonas gallinae

In this study, a pH-sensitive drug release system was prepared by zeolite Y nanoparticles and tannic acid. Zeolite Y nanoparticles were synthesized via hydrothermal synthesis of colloidal suspensions and after that, were coated with tannic acid. In order to evaluate its performance, metronidazole as an anti-protozoan drug was loaded into nanocarriers via immersing method to study the in-vitro drug delivery behavior. This nanocomposite carriers represented pH-sensitive behavior and had more and faster release in acidic medium. In-vitro effects of metronidazole-loaded nanoparticles was measured against Trichomonas gallinae trophozoites in Trypticase Yeast extract Maltose medium. The results suggested that metronidazole-loaded and tannic acid-modified zeolite Y nanoparticles could be a potential anti-trichomonal agent.     

Perspectives and Prospective on Solid Lipid Nanoparticles as Drug Delivery Systems

Combating multiple drug resistance necessitates the delivery of drug molecules at the cellular level. Novel drug delivery formulations have made it possible to improve the therapeutic effects of drugs and have opened up new possibilities for research. Solid lipid nanoparticles (SLNs), a class of colloidal drug carriers made of lipids, have emerged as potentially effective drug delivery systems. The use of SLNs is associated with numerous advantages such as low toxicity, high bioavailability of drugs, versatility in the incorporation of hydrophilic and lipophilic drugs, and the potential for production of large quantities of the carrier systems. The SLNs and nanostructured lipid carriers (NLCs) are the two most frequently used types of nanoparticles. These types of nanoparticles can be adjusted to deliver medications in specific dosages to specific tissues, while minimizing leakage and binding to non-target tissues.